Secrets of Breast Reduction Surgery - I

Toxin treatments were first introduced into clinical practice in the 1980s when ophthalmologists began injecting them into humans. Their use in the cosmetic field was first reported in 1992 for the treatment of glabellar wrinkles. In 1991, Allergan purchased a small toxin-producing company for $9 million. With the increase in cosmetic applications, which have made toxin treatments the most commonly performed aesthetic procedure today, Allergan earned $2.45 billion from toxin treatments in 2015.

Currently, injections into the glabellar muscles remain the most common area for toxin treatments, but they can also be applied to all facial muscles in varying doses. Beyond cosmetic applications, toxin treatments are also successfully used for the treatment of migraine headaches. Neurologists work with carefully selected patients to achieve significant benefits from this treatment.

In cases of excessive sweating in the hands and feet, intradermal toxin treatments can reduce sweating for up to six months.

When performed by individuals without medical training or knowledge of anatomy, toxin treatments can result in unnatural facial appearances and asymmetries, even in mild cases.